# Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care

> **NCT03460483** · NA · COMPLETED · sponsor: **Ohio State University Comprehensive Cancer Center** · enrollment: 1001 (actual)

## Conditions studied

- Endometrial Adenocarcinoma
- Endometrial Carcinoma
- Lynch Syndrome
- Relatives

## Interventions

- **OTHER:** Genetic Counseling
- **OTHER:** Genetic Testing
- **OTHER:** Laboratory Biomarker Analysis
- **PROCEDURE:** Mutation Carrier Screening

## Key facts

- **NCT ID:** NCT03460483
- **Lead sponsor:** Ohio State University Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-30
- **Primary completion:** 2025-06-15
- **Final completion:** 2025-06-15
- **Target enrollment:** 1001 (ACTUAL)
- **Last updated:** 2025-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03460483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03460483, "Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03460483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*